NCT03905135 2022-09-13Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed8 enrolled 18 charts